A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Dren Bio
Dren Bio
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Merck Sharp & Dohme LLC
University of California, Davis
University Health Network, Toronto
Ossium Health, Inc.
Dana-Farber Cancer Institute
Essen Biotech
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NuCana plc
UNC Lineberger Comprehensive Cancer Center
OncoNano Medicine, Inc.
Treeline Biosciences, Inc.
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
Ohio State University Comprehensive Cancer Center
Washington University School of Medicine
Incyte Corporation
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Novartis
City of Hope Medical Center
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
Daiichi Sankyo
Columbia University
City of Hope Medical Center
Indiana University
Cedars-Sinai Medical Center
Pfizer
Presage Biosciences
Eisai Inc.
TopAlliance Biosciences
Rutgers, The State University of New Jersey
University of Nebraska
Columbia University
Eastern Cooperative Oncology Group
Genmab
Seagen Inc.
Fate Therapeutics
Genmab
Sierra Oncology LLC - a GSK company
Bristol-Myers Squibb
Genzada Pharmaceuticals USA, Inc.